Stay in the know with a roundup of the week’s top local stories.

Ajax residents, get ready to celebrate the 159th anniversary of Canada’s Confederation. Join the town on Canada Day at the new Ajax Fairgrounds, located at the Audley Recreation Complex (ARC), from 2 ...

New Delhi: Despite the tightly contested assembly elections in the latest round, no EVM memory check applications were filed across four of the five election states/Union Territories in contrast to ...

A proposal to provide reusable water bottles to Tamil Nadu MLAs sparked jokes in the Assembly, with leaders quipping about bottles being thrown in anger. The light-hearted exchange led to laughter ...

Eli Lilly’s up-to-$2.3 billion acquisition of Ajax Therapeutics is facing its first major public test, and the initial clinical data show why the pharma giant made the bet. The Ajax acquisition was a ...

The Ministry of Defence is taking a two-phase approach to delivering an improved version of the British Army’s Ajax armoured reconnaissance vehicle, restarting trials on the current platform under ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

NEW DELHI: The Supreme Court has dismissed a review petition filed by the Tamil Nadu government in the Mekedatu case, also rejecting its request that the matter be heard in open court instead of ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

Eli Lilly LLY-2.33%decrease; down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...